Bontac Bio-engineering (Shenzhen) Co.
Latest round
- Series B
Last raised
- Mar 2017
Total raised
- Undisclosed
Investors
- 4
About Bontac Bio-engineering (Shenzhen) Co.
, Ltd. is a biotech company that focuses on the research and development of coenzyme series pharmaceutical intermediates and raw materials. In 2014, the company established a full enzyme catalytic coenzyme production line. As of September 2024, it has applied for more than 180 domestic and foreign patents, including more than 170 invention patents. The company's main products include coenzyme series, natural product series, sugar substitute series, etc. It also provides OEM customization services for cosmetics and health products. The company's products are used in nutrition and health, biomedicine, medical beauty and other fields. The company’s revenue is generated by providing coenzyme series pharmaceutical intermediates and raw materials.
Who invested in Bontac Bio-engineering (Shenzhen) Co.
4 investors across 2 rounds
See all investors in Bontac Bio-engineering (Shenzhen) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bontac Bio-engineering (Shenzhen) Co.
Who invested in Bontac Bio-engineering (Shenzhen) Co.?
Bontac Bio-engineering (Shenzhen) Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bontac Bio-engineering (Shenzhen) Co. raised?
Bontac Bio-engineering (Shenzhen) Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bontac Bio-engineering (Shenzhen) Co. last raise money?
Bontac Bio-engineering (Shenzhen) Co.'s most recent round on record is a Series B, in Mar 2017.
What does Bontac Bio-engineering (Shenzhen) Co. do?
Bontac Bio-engineering (Shenzhen) Co. is a biotechnology company.
Where is Bontac Bio-engineering (Shenzhen) Co. headquartered?
Bontac Bio-engineering (Shenzhen) Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Bontac Bio-engineering (Shenzhen) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Bontac Bio-engineering (Shenzhen) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Bontac Bio-engineering (Shenzhen) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.